Although overshadowed by the FDA’s decision to deny Premarket Tobacco Applications (PMTAs) that don’t include “product-specific” evidence addressing flavored vaping products’ “risk posed to youth,” the agency is continuing its purge of products sold by small vape manufacturers without first submitting PMTAs.
Products that were not submitted for review by the Sept. 9, 2020 deadline were supposed to have been removed immediately from the market. The difficult and expensive PMTA process discouraged many small manufacturers from attempting to comply, and many continued to sell products after the deadline.
The FDA Center for Tobacco Products announced Thursday that 29 warning letters were sent in August to vaping manufacturers and sellers, ordering them to remove products from the market or face enforcement actions. According to the agency, these companies have more than 268,000 products registered with the FDA.
Two of the letters sent in August went to manufacturers that submitted PMTAs the FDA refused to accept, and another went to a company that filed PMTAs for some products but not others.
Since our last update on June 4, the FDA has issued 47 warning letters (including the August letters), making a total of 169 so far this year.